vitamin D and non alcoholic fatty liver disease in children

effect of oral vitamin D supplementation in children with non alcoholic fatty liver disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201710002634203

Enrollment

100

Registered

2017-09-19

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine non alcoholic fatty liver disease

Interventions

vitamin D supplementation

oral glucose 5%

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age less than 18 years, children with NAFLD with vitamin D deficiency

Exclusion criteria

Exclusion criteria: age more than 18 years, other chronic liver disease, liver cirrhosis, autoimmune hepatitis, normal vitamin D level, renal failure, cancer, hyper/hypoparathyroidism, hypercalcemia,recent (previous 6 months) supplementation with vitamin D, and treatment with agents affecting calcium/vitamin D metabolism (anticonvulsants, glucocorticoids).

Design outcomes

Primary

Measure	Time frame
change in hepatic fat content, grading of NAFLD, and vitamin D level	—

Secondary

Measure	Time frame
correlation between serum vitamin D level and various clinical, laboratory variables, and grading of NAFLD	—

Countries

Egypt

Contacts

Public Contactmohamed Elkashlan

manger of hospital

mohamedkashlan@yahoo.com00201222337746

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026